Scientist III (In Vivo Studies)
Exelixis
About this role
The Scientist III will support multidisciplinary research teams by designing and executing preclinical in vivo studies in rodents. The role focuses on integrating pharmacokinetics with pharmacodynamics/efficacy and/or toxicology to provide assessments around drug exposure and its relationship to target-engagement and efficacy.
Skills
Qualifications
About Exelixis
exelixis.comExelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Recent company news
BitgetExelixis (EXEL) Has Fallen 2.8% Since Its Previous Earnings Report: Is a Recovery Possible?
4 hours ago
Fierce PharmaExelixis aims to be a top-5 solid tumor drugmaker in the US: CEO
1 month ago
MarketBeatWhat is Zacks Research's Estimate for Exelixis Q3 Earnings?
3 days ago
Investing.com NigeriaExelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Business WireExelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
2 weeks ago
About Exelixis
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Exelixis.
Salary
$90k – $128k
per year